Population differences concerning TNF-á gene polymorphisms in gastric carcinogenesis based on meta-analysis
Theodoros Rokkas, Panos Sechopoulos, Dimitrios Pistiolas, Fotis Kothonas, Georgios Margantinis, Georgios Koukoulis
Henry Dunant Hospital, Athens, Greece
Abstract
Background Recent meta-analyses have studied population differences concerning interleukin (IL)-1 gene polymorphisms in gastric carcinogenesis. In addition to the IL-1 gene cluster, candidate genes include those encoding the pro-inflammatory cytokine tumor necrosis factor (TNF)-á. The aim of the study was to systematically review the role of TNF-á-238 and TNF-á-308 gene polymorphisms (genotypes G/G, G/A, A/A) in gastric carcinogenesis by meta-analyzing all relevant studies to look for any differences concerning TNF-á gene polymorphisms in gastric carcinogenesis.
Methods Extensive English language medical literature searches for human studies were performed up to the end of May 2013, using suitable keywords. Pooled estimates [odds ratio (OR) with 95% confidence intervals (CI)] were obtained using the random-effects model. Heterogeneity between studies was evaluated with the Cochran Q test whereas the likelihood of publication bias was assessed by constructing funnel plots. Their symmetry was estimated by the adjusted rank correlation test.
Results In seventeen studies, from various countries, the TNF-á-308 and TNF-á-238 frequencies of genotypes G/G, G/A, A/A were examined in gastric cancer patients and controls. For TNF-á-308 frequency overall, the pooled ORs with 95%CI for genotype G/G, A/A and G/A were 0.837 (0.712-0.982), 1.430 (1.064-1.923) and 1.145 (0.973-1.348) with respective P values 0.029, 0.018 and 0.104. Subgroup analyses showed significant results for genotype G/G only in Asians [OR=0.774 (0.610-0.983), P=0.036].
Conclusion In this meta-analysis there was an overall statistically significant increased cancer risk associated with TNF-á-308 G/G and A/A genotypes. Subgroup analyses showed significant results for genotype G/G in Asians, whereas no such significant results were found for Caucasians and Hispanics.
Keywords TNF-á-308 gene, TNF-á-238 gene, polymorphism, gastric cancer, meta-analysis
Ann Gastroenterol 2014; 27 (2): 139-148
Gastroenterology Clinic, Henry Dunant Hospital, Athens, Greece
Conflict of Interest: None
Correspondence to: Theodore Rokkas MD, PhD, FACG, AGAF, FEBGH, Gastroenterology Clinic, Henry Dunant Hospital, 192B Alexandras Ave., Athens 11521, Greece, e-mail: sakkor@otenet.gr
Received 25 July 2013; accepted 9 October 2013
Introduction
Gastric cancer (GC) is one of the most common gastrointestinal malignancies worldwide and the second most common cause of cancer related death with over 600,000 deaths per year [1]. Helicobacter pylori (H. pylori) plays an important role in gastric carcinogenesis through physiological and histological changes that H. pylori infection induces in the stomach [2,3]. However, a striking difference exists between the number of infected individuals and the number that go on to develop GC [4-6]. Therefore a multifactorial etiology is possible, with H. pylori infection, dietary factors and host genetic susceptibility all playing a role in its development. Host genetic factors are emerging as key determinants of disease for many cancers [7,8], as genetic variations in pro-inflammatory and anti-inflammatory cytokine genes influence individual response to carcinogenic exposures. Various studies have evaluated the role of pro-inflammatory gene polymorphisms in GC and two recent meta-analyses have examined the role of interleukin (IL)-1 gene cluster polymorphisms in gastric carcinogenesis [9,10]. In addition to the IL-1 gene cluster, candidate genes include those encoding the pro-inflammatory cytokine tumor necrosis factor (TNF)-á and indeed studies on the association between TNF-á gene polymorphisms and gastric carcinoma have been published with discrepant results. A meta-analysis on this subject has been published some years ago [11]. However, in this meta-analysis population differences concerning TNF-á gene polymorphisms in gastric carcinogenesis have not been adequately addressed. The aim of this study therefore was to systematically review the role of TNF-á-308 and TNF-á-238 gene polymorphisms (genotypes G/G, G/A, A/A) in gastric carcinogenesis and in particular to look for population differences by meta-analyzing all relevant studies.
Material and methods
Data identification and extraction
We searched the PubMed, Medline and Embase databases through May 2013 to identify all relevant English language medical literature for human studies under the search text terms; (“stomach neoplasms” OR “stomach” AND “neoplasms” OR “stomach neoplasms” OR “gastric” AND “cancer” OR “gastric cancer”) AND (TNF-á AND «polymorphism, genetic» OR «polymorphism» AND «genetic» OR «genetic polymorphism» OR «polymorphism»). We also performed a full manual search of all review articles, recently published editorials and of retrieved original studies. Data were extracted independently from each study by two of the authors (T.R. and D.P.) by using a predefined form, and disagreements were resolved by discussion with a third investigator and consensus.
Selection criteria
Inclusion and exclusion criteria were delineated before the commencement of the literature search. Thus, eligible studies were included in this meta-analysis if they met all the following criteria: 1) published as full articles; 2) written in English; 3) to be cohort or case control studies. Studies not meeting the aforementioned criteria and in addition studies without data for retrieval and duplicate publications were excluded. When two papers reported the same study, the publication that was more informative was selected.
Statistical analysis
Agreement on the selection of studies between the two reviewers was evaluated by the ę coefficient. We calculated the pooled odds ratios (ORs) and 95% confidence intervals (CIs) and compared outcomes of individual studies by using the fixed effects model [12] (Mantel and Haenszel method), unless significant heterogeneity was present, where the random effects model [13] was used (DerSimonian and Laird method). Forest plots were constructed for visual display of ORs of individual studies. Heterogeneity between studies was evaluated with the Cochran Q test [14] and it was considered to be present if the Q test provided a P value of less than 0.10 [15]. In the presence of significant statistical heterogeneity, sensitivity analyses were performed to exclude any possible influence of a single study. These analyses were achieved by repeating the meta-analyses with exclusion of each individual study one at a time, in order to assess the overall effect of each study on the pooled ORs [15]. This indicates which particular studies are most influential and might help in the evaluation of the possibility that the conclusions result from the influence of a particular study. The likelihood of publication bias was assessed by constructing funnel plots which were obtained by plotting the log ORs vs. precision (1/SE) of individual studies [16]. Their symmetry was estimated by the Begg and Mazumdar adjusted rank correlation test [17], whereas the number of studies missing from a meta-analysis was estimated using Duval and Tweedie’s nonparametric ‘trim and fill’ rank-based method [18]. All analyses were performed by using Comprehensive Meta-analysis software (Version 2, BIOSTAT INC., Englewood, NJ, USA).
Results
Descriptive assessment and study characteristics
A flow chart describing the process of study selection is shown in Fig. 1. Out of 56 titles initially generated by the literature searches, 17 case control studies from various countries remained eligible for meta-analysis [19-35]. Initial agreement between the reviewers for the selection of relevant articles was high [ę = 0.94, 95% CI (0.86-1)].
One of the studies [28] contained separate data from two areas of Italy and therefore in the 17 meta-analyzed studies, conducted in different parts of the world, there were totally 18 sets of data comparing the TNF-á-308 and TNF-á-238 frequencies of genotypes G/G, G/A, A/A in GC patients and controls. The main characteristics of the papers eligible for meta-analysis are shown in Tables 1 and 2.
TNF-á-308
G/G genotype frequency (18 complete sets of data)
The G/G genotype frequencies, in patients and controls, were 2,627/3,452 (76.1%) vs. 3,854/4,964 (77.64%). There was significant heterogeneity among studies (Q =28.479, df(Q)=17, I2= 40.3%, P=0.04) but no publication bias (P=0.13) (Fig. 2). The meta-analysis overall (random effects model) showed pooled OR=0.837 (0.712-1.021), test for overall effect Z= -2.177, P=0.029 by random effects model] (Fig. 2). Due to significant heterogeneity, except for using the random effects model, sensitivity analyses were performed. Thus subgroup analyses were made, grouping studies by geographical location and population composition (Asians, Caucasians and Hispanics) (Fig. 3). These analyses showed significant results for Asians [OR=0.774, 95% CI (0.61-0.983), Z=-2.098, P=0.036), whereas no significant results were found for Caucasians and Hispanics [OR=0.871, 95% CI (0.686-1.107), Z=-1.126, P=0.260) and OR=1.158, 95% CI (0.591-2.269), Z=0.429, P=0.668) respectively].
G/A genotype frequency (18 complete sets of data)
The G/A genotype frequencies, in patients and controls, were 672/3,452 (19.46%) vs. 844/4,964 (17%). There was significant heterogeneity (Q=28.08, df(Q)=17 , I2=39.45%, P=0.044) but no publication bias (P=0.45) (Fig. 4). The meta-analysis showed no significant results [pooled OR=0.874 (0.717-1.065), Z=-1.338, P=0.181 (random effects model)] (Fig. 4). The subgroup analyses showed no significant results for Caucasians, Asians or Hispanics.
A/A genotype frequency (18 complete sets of data)
The A/A genotype frequencies, in patients and controls, were 151/3,452 (4.3%) vs. 266/4,964 (5.3%). There was neither significant heterogeneity (Q=11.952, df(Q)=14 , I2=0%, P=0.021) nor publication bias (P=0.12) (Fig. 5). The meta-analysis overall showed significant results [pooled OR=1.430 (1.064-1.923), Z=2.371, P=0.018 by both fixed and random effects model] (Fig. 5). Subgroup analyses showed no significant results for Caucasians, Asians and Hispanics.
TNF-a-238
G/G genotype frequency (7 complete sets of data)
The G/G genotype frequencies in patients and controls were 1,447/1,606 (90%) vs. 2,053/2,267 (90.5%) [pooled OR with 95% CI=0.940 (0.747-1.183), test for overall effect Z=-0.527, p=0.598 by both fixed and random effects model]. There was neither significant heterogeneity (Q=4.816, df(Q)=6 , I2=0 %, P=0.568) nor publication bias (P=0.29) (Fig. 6). The subgroup analyses showed no significant results for Caucasians, Asians and Hispanics.
G/A genotype frequency (7 complete sets of data)
The G/A genotype frequencies in patients and controls were 149/1,606 (9.2%) vs. 198/2,267 (17%) [pooled OR with 95% CI=1.088 (0.856-1.383), test for overall effect Z= 0.690, P=0.490 by both fixed model and random effects model]. There was neither significant heterogeneity (Q=4.415, df(Q)=6, I2=0%, P=0.621) nor publication bias (P=0.36) (Fig. 6). Subgroup analyses showed no significant results for Caucasians, Asians and Hispanics.
A/A genotype frequency (5 complete sets of data)
The G/A genotype frequencies in patients and controls were 10/1,606 (0.6%) vs. 16/2,267 (0.7%) [pooled OR with 95% CI=1.3 (0.276-6.118), test for overall effect Z=0.332, P=0.740 (by random effects model)]. There was significant heterogeneity (Q=10.766, df(Q)=4, I2=62.845%, P=0.029) but no publication bias (P=0.32) (Fig. 6). Subgroup analyses showed no significant results for Caucasians, Asians and Hispanics.
Discussion
Besides environmental factors, cytokine gene polymorphisms have been linked to inter-individual differences in GC susceptibility. Indeed, host genetic factors are emerging as key determinants of disease for many cancers [7,8] as genetic variations in pro-inflammatory and anti-inflammatory cytokine genes influence individual response to carcinogenic exposures. Since El-Omar et al first reported an association between IL-1B and IL-1RN gene polymorphisms and an increased risk of gastric atrophy, as well as GC [36], many investigators have explored the association of these gene polymorphisms with the risk of GC. Two recent meta-analyses have explored the role of IL-1 gene cluster polymorphisms in gastric carcinogenesis [9,10].
In addition to polymorphisms in IL genes, the polymorphisms in the promoter region of TNF-á gene have been studied in relation to cancer. TNF-á is the most important proinflammatory cytokine involved in the growth, differentiation, cellular function and survival of many cells. It is produced by diverse kinds of cells, such as macrophages, neutrophils, fibroblasts, keratinocytes, NK cells, T and B cells, and tumor cells [37]. TNF-á has been reported to play an important role in the pathogenesis of cancer [38]. As transcription of TNF-á is regulated under genetic control, recent studies [39-41] have shown that its promotor polymorphisms at 2238 (rs361525), 2308 (rs1800629), 2857 (rs1799724), and 21031 (rs1799964) positions could regulate TNF-á production. Two polymorphisms in TNF-á gene have been studied in greater detail than others, i.e. TNF-á-308 and TNF-á-238; in fact TNF-á-308 polymorphism has been confirmed as a risk factor for a range of cancers, such as breast and hepatocellular cancers [42,43]. However, the significance of TNF-á-238 polymorphism is less clear, but because a putative repressor site is located in a 25-base stretch that includes position -238, this polymorphism has been associated with decreased susceptibility to cancers [44].
The results of our meta-analysis showed that overall there was no association between TNF-á-308 G/A genotype and GC risk, but there was an overall statistically significant increased risk associated with TNF-á-308 G/G and A/A genotypes. However, as shown by sensitivity (subgroup) analysis, this association was limited to studies in Asians and no association was found in studies concerning Caucasians and Hispanics. The reason for these discrepant results is unclear and differences in sample size, methodologies, ethnicities and dominance of different etiologic factors in different populations could contribute to this heterogeneity of results. However, studies have suggested that the frequency of genetic markers often shows high variation among various ethnic and racial groups [45,46]. No significant results were found concerning TNA-á-238 frequency for genotypes G/G, A/A, G/A and these results are similar to those found by others [47]. According to these results it seems likely that in Asians, TNF-á-308 gene polymorphism plays an important role as host genetic factor predisposing to gastric carcinogenesis and it could be used as a screening marker. Indeed, in countries like Japan this could be of particular importance since in this country many efforts have been made in screening and accurate early detection of GC [48,49], considering that half of the global total of GC occurs in Eastern Asia where the highest mortality rates are expected (28.1 per 100,000 in men, 13.0 per 100,000 in women) [50].
Among the strengths of this meta-analysis are the relatively large number of cases and controls, the methods we used to examine the robustness of our results and the fact that the statistically significant positive relationship we found was consistent over the years as judged by the results of the cumulative meta-analysis of studies, ordered by the year of publication. However, we acknowledge that this meta-analysis also has limitations, such as the significant heterogeneity found in some of the analyses. We tackled this problem by assessing the homogeneity of the effects across studies using suitable heterogeneity tests, sensitivity, meta-regression and publication bias analyses as outlined in detail in the statistical analysis section.
In conclusion, in this meta-analysis the comparison of genotype frequencies between the control group and individuals with GC showed that there was a statistically significant increased risk associated with G/G and A/A genotype which was limited to studies from Asian countries, whereas no association was found in studies concerning Caucasians and Hispanics. According to these results it seems likely that in Asians, TNF-á-308 gene polymorphism plays an important as host genetic factor predisposing to gastric carcinogenesis. However, since the magnitude of each etiologic factor might differ among populations, large studies examining the interaction between host genetic factors and environmental factors, in association with anatomical or histological subtypes of GC and H. pylori positivity, in different geographic areas and ethnic groups, are required to elucidate the real significance of host genetic factors in gastric carcinogenesis.
|
Summary Box |
|
What is already known:
What the new findings are:
|
References
1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
5. Sipponen P. Gastric cancer-a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol (Suppl) 1994;201:24-27.
6. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-1528.
7. Ponder BA. Cancer genetics. Nature 2001;411:336-341.
8. Peto J, Houlston RS. Genetics and the common cancers. Eur J Cancer 2001;37(Suppl 8):S88-S96.
9. Camargo MC, Mera R, Correa P, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1674-1687.
10. Kamangar F, Cheng C, Abnet CC, Rabkin CS. Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1920-1928.
11. Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. British Journal of Cancer 2008;98:1443-1451.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 1959;22:719-748.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
14. Cochran WG. The compination of estimates from different experiments. Biometrics 1954;8:101-129.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
16. Copas JB, Shi JQ. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res 2001;10:251-265.
17. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
18. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-463.
19. Wu MS, Huang SP, Chang YT, et al. Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 2002;185:106-109.
20. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-1201.
21. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-371.
22. Wu MS, Wu CY, Chen CJ, et al. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617-623.
23. Lee SG, Kim B, Yook JH, et al. TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 2004;28:75-82.
24. Garza-González E, Bosques-Padilla FJ, El-Omar E, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005;114:237-241.
25. Lee JY, Kim HY, Kim KH, et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 2005;225:207-714.
26. Li C, Xia B, Yang Y, Li J, Xia HH. TNF gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in Chinese population. Am J Gastroenterol 2005;100:290-294.
27. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005;26:631-636.
28. Perri F, Piepoli A, Bonvicini C, et al. Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine 2005;30:293-302.
29. Zambon CF, Basso D, Navaglia F, et al. Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005;29:141-152.
30. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006;17:117-125.
31. Kim N, Cho SI, Yim JY, et al. The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastro-duodenal diseases in Korea. Helicobacter 2006;11:105-112.
32. Morgan DR, Dominguez RL, Keku TO, et al. Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin Gastroenterol Hepatol 2006;4:1103-1111.
33. García-González MA, Lanas A, Quintero E, et al.; Spanish Gastroenterological Association AEG. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol 2007;102:1878-1892.
34. Hou L, El-Omar EM, Chen J, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007;28:118-123.
35. Sugimoto M, Furuta T, Shirai N, et al. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007;22:51-59.
36. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
37. Anderson GM, Nakada MT, DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 2004;4:314-320.
38. Wang SS, Purdue MP, Cerhan JR, et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One 2009;4:e5360.
39. Huizinga TW, Westendorp RG, Bollen EL, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997;72:149-153.
40. Hellmig S, Fischbach W, Goebeler-Kolve ME, et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol 2005;100:2644-2649.
41. Lindholm E, Bakhtadze E, Cilio C, et al. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One 2008;3:e2546.
42. Shen C, Sun H, Sun D, et al. Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011;126:763-770.
43. Yang Y, Luo C, Feng R, Bi S. The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2011;137:947-952.
44. Jang WH, Yang YI, Yea SS, et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001;166:41-46.
45. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-1248.
46. Ioannidis JP, Ntzani EE, Trikalinos TA. ‘Racial’ differences in genetic effects for complex diseases. Nat Genet 2004;36:1312-1318.
47. Zhou P, Lv GQ, Wang JZ, et al. The TNF-Alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS One 2011;6:e22092.
48. Uedo N, Takeuchi Y, Ishihara R. Endoscopic management of early gastric cancer: endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese high-volume center and literature review. Ann Gastroenterol 2012;25:281-290.
49. Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 2013;26:11-22.
50. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.